E
JNCE

Ergoteles’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Ergoteles’s Portfolio JNCE Stock Details JNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-400,000
Closed -$740K – 1714
2023
Q1 		$740K Buy
+400,000
New +$740K 0.03% 604